NetworkNewsBreaks – Bionano Genomics, Inc. (NASDAQ: BNGO) Closes $18M Follow-On
Bionano Genomics (NASDAQ: BNGO), a genome analysis company that provides tools and services based on its Saphyr(R) system to scientists and clinicians conducting genetic research and patient testing, has closed an underwritten public offering of 54,546,000 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and common warrants to purchase up to an aggregate of 54,546,000 shares of common stock. The resulting gross proceeds to Bionano from the offering, not including any proceeds that may be received upon exercise of the common warrants, total roughly $18 million. Bionano plans to utilize the proceeds toward…







